Danazol treatment of advanced prostate cancer: clinical and hormonal effects
Danazol treatment of 19 advanced prostate cancer patients showed no objective remissions but stable disease in 15.8% of cases, alongside significant tumor flare reactions and potential treatment-related mortality.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (14)
- Danazol effects on gonadotropin basal levels and pituitary responsiveness to LH-RH in immature male rats via openalex
- Danazol increasingly used. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol treatment of advanced breast cancer via openalex
- Effects of Danazol on pituitary gonadotrophins in post-menopausal women via openalex
- Further studies on danazol interference in testosterone radioimmunoassays via openalex
- Further studies on danazol interference in testosterone radioimmunoassays. via openalex
- Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol) via openalex
- Pituitary gonadotropin responsiveness with danazol via openalex
- The effect of danazol on anterior pituitary function via openalex
- W6643992471 via openalex
- doi:10.1002/pros.2990050405 via openalex
- doi:10.1095/biolreprod10.4.438 via openalex
- doi:10.1016/s0015-0282(16)43953-1 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T18:12:33.072680+00:00
- pubmed
- last seen: 2026-10-08T21:24:17.697085+00:00